INTRODUCTION: The benefit of a cardiac rehabilitation (CR) program for patients with Chagas heart failure (CHF) remains unclear. Therefore, we aimed to investigate the effects of CR for CHF patients. METHODS: A single-arm pilot study, including 12 patients with CHF, was performed. Patients participated in an 8-month physical exercise intervention, comprising aerobic, strength, and stretching exercises (3 times per week, 60 minutes per session). Nutritional and pharmaceutical counseling were also performed. Functional capacity (cardiopulmonary exercise test), muscle respiratory strength (manovacuometry), and body composition (anthropometry and skinfolds) were evaluated at baseline, and after 4 and 8 months of intervention. Cardiac function (echocardiography), biomarkers (lipid profile, glucose, and glycated hemoglobin) and quality of life (Minnesota Living with Heart Failure Questionnaire) were assessed at baseline and at the end of the intervention. RESULTS: Seven of 12 patients included in the study completed the 8-month follow-up period. Only 2 moderate adverse events occurred during the exercise training. Functional capacity improved after 4 months of CR, while left ventricular ejection fraction (LVEF) and respiratory strength improved after 8 months. Patients with right ventricular (RV) dysfunction at baseline exhibited an improvement in functional capacity after 4 months, and improvements in left ventricular (LV) diastolic pressure, respiratory strength, and quality of life at the end of follow-up. Conversely, those with normal baseline RV function demonstrated LVEF increases that were not observed in patients with RV dysfunction. CONCLUSIONS: CR was feasible, safe, and has important clinical benefits for patients with CHF, specifically for cardiac function and muscle respiratory strength.
INTRODUCTION: The benefit of a cardiac rehabilitation (CR) program for patients with Chagas heart failure (CHF) remains unclear. Therefore, we aimed to investigate the effects of CR for CHFpatients. METHODS: A single-arm pilot study, including 12 patients with CHF, was performed. Patients participated in an 8-month physical exercise intervention, comprising aerobic, strength, and stretching exercises (3 times per week, 60 minutes per session). Nutritional and pharmaceutical counseling were also performed. Functional capacity (cardiopulmonary exercise test), muscle respiratory strength (manovacuometry), and body composition (anthropometry and skinfolds) were evaluated at baseline, and after 4 and 8 months of intervention. Cardiac function (echocardiography), biomarkers (lipid profile, glucose, and glycated hemoglobin) and quality of life (Minnesota Living with Heart Failure Questionnaire) were assessed at baseline and at the end of the intervention. RESULTS: Seven of 12 patients included in the study completed the 8-month follow-up period. Only 2 moderate adverse events occurred during the exercise training. Functional capacity improved after 4 months of CR, while left ventricular ejection fraction (LVEF) and respiratory strength improved after 8 months. Patients with right ventricular (RV) dysfunction at baseline exhibited an improvement in functional capacity after 4 months, and improvements in left ventricular (LV) diastolic pressure, respiratory strength, and quality of life at the end of follow-up. Conversely, those with normal baseline RV function demonstrated LVEF increases that were not observed in patients with RV dysfunction. CONCLUSIONS: CR was feasible, safe, and has important clinical benefits for patients with CHF, specifically for cardiac function and muscle respiratory strength.
Authors: Linda Long; Ify R Mordi; Charlene Bridges; Viral A Sagar; Edward J Davies; Andrew Js Coats; Hasnain Dalal; Karen Rees; Sally J Singh; Rod S Taylor Journal: Cochrane Database Syst Rev Date: 2019-01-29
Authors: Yasmin Pedra-Rezende; Juliana M C Barbosa; Ana Cristina S Bombaça; Luiza Dantas-Pereira; Daniel Gibaldi; Glaucia Vilar-Pereira; Hílton Antônio Mata Dos Santos; Isalira Peroba Ramos; Natália Lins Silva-Gomes; Otacilio C Moreira; Joseli Lannes-Vieira; Rubem F S Menna-Barreto Journal: Front Immunol Date: 2021-11-04 Impact factor: 7.561
Authors: Igor Lucas Geraldo Izalino de Almeida; Luciano Fonseca Lemos de Oliveira; Pedro Henrique Scheidt Figueiredo; Rafael Dias de Brito Oliveira; Thayrine Rosa Damasceno; Whesley Tanor Silva; Lucas Frois Fernandes de Oliveira; Matheus Ribeiro Ávila; Vanessa Pereira Lima; Ana Thereza Chaves Lages; Mauro Felippe Felix Mediano; Manoel Otávio Costa Rocha; Henrique Silveira Costa Journal: Rev Soc Bras Med Trop Date: 2022-03-14 Impact factor: 1.581
Authors: Luiz Fernando Rodrigues Junior; Fernanda de Souza Nogueira Sardinha Mendes; Vivian Liane Mattos Pinto; Paula Simplicio da Silva; Gilberto Marcelo Sperandio da Silva; Roberta Olmo Pinheiro; Andréa Silvestre de Sousa; Mauro Felippe Felix Mediano Journal: J Res Med Sci Date: 2020-02-20 Impact factor: 1.852
Authors: Guilherme Wesley Peixoto da Fonseca; Tania Garfias Macedo; Nicole Ebner; Marcelo Rodrigues Dos Santos; Francis Ribeiro de Souza; Charles Mady; Liliam Takayama; Rosa Maria Rodrigues Pereira; Wolfram Doehner; Stefan D Anker; Carlos Eduardo Negrão; Maria Janieire de Nazaré Nunes Alves; Stephan von Haehling Journal: ESC Heart Fail Date: 2020-08-28